JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Skyworks Solutions
SWKS
$10.6B
| $53M | 0.01% |
558,566
-145,976
| -21% | -$15.2M |
|
952
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $52.8M | 0.01% |
890,357
-68,907
| -7% | -$3.98M |
|
953
BGC Group
BGC
$4.89B
| $52.8M | 0.01% |
5,429,884
+614,540
| +13% | +$6.2M |
|
954
CubeSmart
CUBE
$9.41B
| $52.7M | 0.01% |
1,822,532
-2,116,428
| -54% | -$59.1M |
|
955
Mativ Holdings
MATV
$711M
| $52.4M | 0.01% |
1,155,154
+370,347
| +47% | +$16.1M |
|
|
ECOL
956
DELISTED
US Ecology, Inc.
ECOL
| $52.3M | 0.01% |
1,025,932
+8,793
| +0.9% | +$443K |
|
957
PUT
GE Aerospace
GE
$384B
| $52.3M | 0.01% |
625,611
-58,592
| -9% | -$5.59M |
|
|
STRP
958
DELISTED
Straight Path Communications Inc.
STRP
| $52.1M | 0.01% |
286,770
+96,801
| +51% | +$17.6M |
|
959
MKS Inc
MKSI
$20.6B
| $52.1M | 0.01% |
551,457
+27,192
| +5% | +$2.71M |
|
960
Westamerica Bancorp
WABC
$1.37B
| $52M | 0.01% |
873,462
-8,304
| -0.9% | -$488K |
|
|
UN
961
DELISTED
Unilever NV New York Registry Shares
UN
| $51.9M | 0.01% |
920,867
+174,532
| +23% | +$10.1M |
|
|
MON
962
CALL
DELISTED
Monsanto Co
MON
| $51.8M | 0.01% |
443,500
+144,200
| +48% | +$17.2M |
|
|
BIVV
963
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $51.7M | 0.01% |
958,676
+693,074
| +261% | +$37.9M |
|
964
Darling Ingredients
DAR
$9.44B
| $51.5M | 0.01% |
2,838,608
+91,664
| +3% | +$1.58M |
|
965
Gen Digital
GEN
$17.5B
| $51.3M | 0.01% |
1,826,953
-563,030
| -24% | -$16.8M |
|
966
Dana Inc
DAN
$3.06B
| $51M | 0.01% |
1,591,970
+85,968
| +6% | +$2.65M |
|
|
ENLK
967
DELISTED
EnLink Midstream Partners, LP
ENLK
| $50.7M | 0.01% |
3,301,557
+160,506
| +5% | +$2.52M |
|
968
PUT
JD.com
JD
$44.5B
| $50.5M | 0.01% |
1,220,000
+735,000
| +152% | +$28.9M |
|
969
Regenxbio
RGNX
$708M
| $50.4M | 0.01% |
1,516,908
+246,581
| +19% | +$7.43M |
|
|
SWP
970
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
| $50.4M | 0.01% |
410,271
-214,334
| -34% | -$25.7M |
|
971
McCormick & Company Non-Voting
MKC
$14.2B
| $50.2M | 0.01% |
984,318
+320,776
| +48% | +$16M |
|
|
PSXP
972
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $50.2M | 0.01% |
958,068
+106,321
| +12% | +$5.29M |
|
|
EEP
973
DELISTED
Enbridge Energy Partners
EEP
| $50.1M | 0.01% |
3,630,033
+14,003
| +0.4% | +$204K |
|
974
Curtiss-Wright
CW
$25.5B
| $49.9M | 0.01% |
409,707
-48,686
| -11% | -$5.74M |
|
975
TTM Technologies
TTMI
$14.5B
| $49.8M | 0.01% |
3,177,215
-639,487
| -17% | -$10.3M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.